Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model

By Abramjuk Claudia   Lein Michael   Rothaug Winfried   Krell Hans-Willi   Loening Stefan   Jung Klaus  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Etiasa on the expression of matrix metalloproteinase-2 and tumor necrosis factor-α in a rat model of ulcerative colitis

By        

Molecular Medicine Reports, Vol. 6, Iss. 5, 2012-01 ,pp. : 996-1000

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effect of a tissue kallikrein 1 and tissue inhibitor of matrix metalloproteinase 1 coexpression vector on the proliferation of rat vascular smooth muscle cells

By            

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5671-5678

Spandidos Publications

Access to resources Recommend Favorite

A review of the anti-tumor effect of the combined administration of a cyclooxygenase-2 selective inhibitor and a non-specific immunostimulant protein-bound polysaccharide on an advanced colon cancer model using colon cancer cell lines

By              

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 509-514

Spandidos Publications

Access to resources Recommend Favorite

Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 1587-1594

Spandidos Publications

Access to resources Recommend Favorite